Clinical trial
Effect of Olmesartan or Amlodipine on Serum Angiotensin(1-7) Levels and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
NCT05189015 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Olmesartan or Amlodipine on Serum Angiotensin(1-7) Levels and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2021
- Completion date
- June 30, 2023
- Enrollment
- 80 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angiotensin/renin/aldosterone hypertension, diabetes mellitus, type 2, hypertension